BUSINESSWEEK ONLINE : DECEMBER 11, 2000 ISSUE
[an error occurred while processing this directive] [an error occurred while processing this directive]
INTERNATIONAL -- EUROPEAN BUSINESS Biotech IPOs in Europe ACTELION Swiss maker of cardiovascular drugs is up 190% since its April IPO EVOTECH Stock of German genomics firm is up 346% in 12 months LION BIOSCIENCE German biotech software provider is up 73% since its August IPO MEDIGENE German gene therapy company. Stock up 92% since June TRANSXENOGEN British protein drugmaker's stock has doubled since July DATA: WESTLB PANMURE, MEHTA PARTNERS _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _					RELATED ITEMS Biotech Is Back--but the Prognosis Is Iffy (int'l edition) TABLE: Biotech IPOs in Europe INTERACT E-Mail to Business Week Online

Copyright 2000-2008, by The McGraw-Hill Companies Inc. All rights reserved. Terms of Use   Privacy Notice